Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.
Cristina MerkhoferShasank ChennupatiQin SunKeith D EatonRenato G MartinsScott D RamseyBernardo H L GoulartPublished in: JCO oncology practice (2021)
Participation in a 2L trial was associated with a $6,663 per month cost savings to health care payers for the duration of trial participation. Further studies are necessary to elucidate differences in cost savings from trial participation for Medicare and commercial payers. If confirmed, these results support health care payer investment in programs to improve clinical trial access and enrollment.